During the past decade several new antiepileptic drugs (AEDs) have become available, including new formulations of some of the older medications. Understanding the pharmacokinetics of the new AEDs is important because they are primarily used for adjunctive therapy and interactions with other medications can result in significant toxicities. The new-generation AEDs do not cause serious morbidity in overdose, and treatment is primarily supportive. Specific medications should be chosen based on the patient's history and presentation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.emc.2010.09.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!